本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。

【参】六角形画像(NEWS)

H1

NEWS

パンくずリスト

ホーム > Kidswell Bio Corporation > NEWS

★IR：カテゴリメニュー

タブV2

All
IR Library
Topics

2022/03/17

Column about SHED (Stem cells from Human Exfoliated Deciduous teeth) has posted in the website of AMED iD3 Catalyst Unit.

Column about SHED (Stem cells from Human Exfoliated Deciduous teeth) has posted in the website of AMED iD3 Catalyst Unit.
(The below link will direct you to a third-party site.)

25th Column
Biotech Engineering Company, Striving for Value Creation
- For Comprehensive Healthcare System for Children as well as Families, and Society -

https://id3catalyst.jp/e/column25.html

2025/05/26

IR Library

Kidswell Bio and Ciome Bioscience Enter into Master Service Agreement with Mycenax for Development of New Biosimilar Drugs [PDF：302KB]
2025/05/22

IR Library

Selected for the MHLW’s Subsidy Program Supporting the Development of Domestic Manufacturing Facilities for Biosimilars Three-Company Consortium Commences Collaboration for Facility Development [PDF：337KB]
2025/05/13

IR Library

[Presentation] Financial Results for FY 2024 [PDF：1487KB]
2025/05/13

IR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 [PDF：379KB]
2025/04/15

IR Library

S-Quatre to Present Novel Large-Scale Manufacturing Method for SQ-SHED at ISCT 2025
2025/03/31

IR Library

Notice regarding one-time gains and expenses, and revision of consolidated financial forecast [PDF：238KB]
2025/03/31

IR Library

S-Quatre and Mochida Sign Agreement to jointly develop Stem cells from human exfoliated deciduous teeth (SHED) based treatment for Pediatric Cerebral Palsy and Traumatic Brain Injury [PDF：164KB]
2025/03/05

IR Library

3Q FY2024 update from OMEGA Investment [PDF：749KB]
2025/02/12

IR Library

[Presentation] Financial Results for 3Q FY 2024 [PDF：1378KB]
2025/02/12

IR Library

Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2025 [PDF：326KB]

1
2
3
4
5
6
7
8
9
10
次へ

2019/11/22

topics

Announcement on Series B Funding by Heartseed Inc.
2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]
2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]
2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]
2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]
2019/02/05

topics

FY2018 3Q IR Meeting Information [PDF：2408KB]
2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]
2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：1833KB]
2019/01/17

topics

[Announcement] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：348KB]
2018/09/28

topics

Submission of New Drug Application in Japan of Darbepoetin alfa Biosimilar [PDF：169KB]

1
2
3
4
次へ